One of the major challenges drug developers grapple with in the rare diseases area is the dearth of reliable and accurate epidemiology studies. We bridge this gap by conducting in-depth interviews with the key opinion leaders and exhaustive literature searches in the 7MM [the US, EU4 (Germany, Italy, Spain, France) and the UK, and Japan] geographies. Our patient-based model approach garners insights around the patient journey, helping our partners understand the treatable patient pool for a rare indication. The in-depth epidemiological assessment will help track all the updates regarding the key challenges and unmet needs in the emerging market and how companies are tackling the rising prevalence.

• 10 Years Forecast
• Disease Risk and Burden
• Risk of disease by Segmentation
• Patient Segmentation

Epidemiology Insights provides a framework for epidemiological research and understanding of various indications, such as prevalence/incidence and geographic distribution, clinical manifestations, etiology, pathophysiology, severity, and diagnosis. Our in-depth indication epidemiology analysis will assist you in tracking the growth opportunities for rare diseases across various geographies.

The drug development process is long and expensive; thus, an innovator must understand the market one is getting into.

Key strengths of our models include:

• 10 Years Market Forecast
• Major Drugs Uptake
• Impact of Upcoming Therapies
• Current Treatment Practices
• Key Cross Competition

Our keen market forecast insights keep clients up to date on recent developments in the healthcare industry and provide an edge in the competitive pharmaceutical market, which further assists them in understanding the granular view of the market and how the market will evolve over the next decade.

For any orphan indication, putting the right price on a drug is extremely challenging given the lack of quality-adjusted life year health technology assessments, and limited analogs. By understanding the key elements that define the payer’s purchasing decision and the growing focus on value-based pricing, we help our partners develop the optimal pricing strategy significantly improve their product’s profitability and market share.

We are a plinary team with years of market access, pricing, and reimbursement experience. This enables us to weigh in data and market research advice from payers/KOLs, understand the future environment, and provide future-proof advice.

Unsure which indication to focus on? Is there a bigger market potential in indication A compared to indication B? These are some of the questions innovators grapple with. Given the long duration of drug development, huge capital requirement, and high failure rate, it becomes essential for the players to understand the granularity of this therapy area and how to play in the market.

DelveInsight offers a solution by walking clients through the current and evolving standards of care to comprehensively estimate the correct value and physician/payer’s perspective, helping them define the right target patient populations and invest wisely in lucrative indications.

DelveInsight analysts collaborate with the client team to develop intelligent criteria, create assessment scenarios based on reliable parameters of importance, and define situations as a result of potential successes and failures. Our Indication Prioritization service helps companies create a solid strategy for R&D by understanding future market dynamics through market modeling, unmet medical needs for future understanding of treatment regimens, and so on.

Whether in development or commercial activities, companies frequently seek partnerships that can lead to a win-win situation for the parties involved. The prioritizing interests create the inherent challenge of finding another company with similar interests. DelveInsight, with its proprietary partnering methodology and robust network, helps clients navigate through complex torrents of industry collaborations and assists in identifying the right partner(s) for drug development or commercialization. Through assessing unmet needs and strategic alignment and validating of business perspectives, we help scout the right candidates for a potential collaboration. Our partner assessment services also help the client in identify, monitor, and evaluate organizational barriers for maintaining a strong market foothold.

Key takeaways from our service include:

• Elucidatory description of the field of interest for tracking intelligent leads
• Asset and technology evaluation using predefined landscaping parameters
• A transparent process with real-time updates allows for an understanding of the progress
• Differentiating potential lead's levels of interest for stratified engagement

Along with the syndicated services, we also offer solutions tailor-made to the specific needs of our partners. Our customized offerings are designed to meet your specific research needs. Customer-centric, solution-oriented approach to assisting our client partners gain an advantage and amplify their growth prospects. We believe in adding value to our customer's businesses by accelerating their growth through strategic advisory services that assist in making sound business decisions. Our customized services help create opportunistic paths strategically aligned with our client's vision.

Some of the key services custom-made for our partners include:

• Disease Burden and Unmet Needs